Literature DB >> 12709145

Use of intramuscular ketamine for endoscopy sedation in children.

Albert K Law1, Daniel K Ng, Keung-Kit Chan.   

Abstract

OBJECTIVE: To report the experience of the use of intramuscular (IM) ketamine for endoscopy sedation in children.
METHODOLOGY: Children over 6 months of age scheduled for elective endoscopy - esophagogastroduodenoscopy (EGD), bronchoscopy and nasopharyngolaryngoscopy (NPL) were enrolled for (2 mg/kg to 3 mg/kg) intramuscular ketamine sedation. A repeated dose of 2 mg/kg intramuscular ketamine was administered to those who failed the first sedation. Alternative sedation (intravenous midazolam and fentanyl) was given to children who failed ketamine sedation twice. Sedation was regarded as successful if the procedure was completed by endoscopist with a single dose of ketamine.
RESULTS: Sixty children were enrolled for the study. Overall success rate in our patients was 78.3%. Failure rate in infants was 50%, i.e. 4 out of 8. For children aged 1-7, the failure rate was 32%. Failure rate dropped markedly to 6.7% for those older than 7 years of age, and it showed significant difference when compared with the other two groups. Two cases of laryngospasm were experienced in the present study.
CONCLUSION: Intramuscular ketamine is an effective medication for sedation in endoscopy undertaken in children over age 7 years, but it should be avoided with children under age 7 because of the high failure rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709145     DOI: 10.1046/j.1442-200x.2003.01680.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

1.  General considerations and updates in pediatric gastrointestinal diagnostic endoscopy.

Authors:  Yong Joo Kim
Journal:  Korean J Pediatr       Date:  2010-09-13

2.  Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain.

Authors:  Chainllie Young; Vesna Jevtovic-Todorovic; Yue-Qin Qin; Tatyana Tenkova; Haihui Wang; Joann Labruyere; John W Olney
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Repeated Doses of Ketamine Affect the Infant Rat Urogenital System.

Authors:  Hulya Kasıkara; Nuran Sungu; Mustafa Arslan; Aysegul Kucuk; Levent Ozturk; Nigar Afandiyeva; Mustafa Kavutcu
Journal:  Drug Des Devel Ther       Date:  2021-03-11       Impact factor: 4.162

4.  [Remifentanil-ketamine vs. propofol-ketamine for sedation in pediatric patients undergoing colonoscopy: A randomized clinical trial].

Authors:  Feride Karacaer; Ebru Biricik; Murat Ilgınel; Çağatay Küçükbingöz; Mehmet Ağın; Gökhan Tümgör; Yasemin Güneş; Dilek Özcengiz
Journal:  Braz J Anesthesiol       Date:  2018-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.